Patara Pharma (PA101 global rights)
Buildings and Property
Patara Pharma (PA101 global rights) valuation and funding history | Last updated: September 4, 2018 | 1 funding rounds
Current Valuation
N/A
As of September 4, 2018
Total Funding Raised
N/A
Across 1 round
Last Round
Buyout/LBO†
Amount undisclosed
Last Funding
Sep 2018
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| September 4, 2018 | Buyout/LBO† | Undisclosed | N/A | - |
Valuation Analysis
Current Valuation Metrics
Patara Pharma (PA101 global rights) is currently valued at N/A as of September 4, 2018.
Explore More Data
Detailed analysis for Patara Pharma (PA101 global rights)
What is Patara Pharma (PA101 global rights) Worth in 2026?
Patara Pharma (PA101 global rights) is a leading private company in the Buildings and Property sector. Track Patara Pharma (PA101 global rights)'s valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Patara Pharma (PA101 global rights) Valuation is Determined
Private company valuations like Patara Pharma (PA101 global rights)'s are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.